Drug Delivery Devices Global Market Report 2023 – Drug Delivery Devices Global Market Report 2023 – By Route Of Administration (Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, Nasal Drug Delivery, Transmucosal Drug Delivery, Implantable Drug Delivery), By Patient Care Setting (Hospitals, Diagnostic Centers, Ambulatory Surgery Centers/Clinics, Home Care Settings, Other Patient Care Settings), By Application (Cancer, Infectious Diseases, Respiratory Diseases, Diabetes, Cardiovascular Diseases, Autoimmune Diseases, Central Nervous System Disorders, Other Applications) – Market Size, Trends, And Market Forecast 2023-2032 ...(expand)

Drug delivery devices are used to deliver specific drugs to a specific part of the body to cure diseases. Drug delivery devices used in various patient care settings, such as hospitals, diagnostic centers, clinics, and home care settings, are included in this market. For further insights on the drug delivery devices market, request a sample here

The drug delivery devices market growth is aided by rising prevalence of chronic diseases such as cardiovascular diseases, diabetes, cancer and other diseases. However, some drug delivery devices market restraints include regulatory changes related to medical devices. For further insights on the drug delivery devices market, request a sample here

The drug delivery devices market is expected to reach $115.09 billion in 2027 at a rate of 7.0%. For further insights on the drug delivery devices market, request a sample here

The global drug delivery devices market is segmented as
1) By Route Of Administration: Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, Nasal Drug Delivery, Transmucosal Drug Delivery, Implantable Drug Delivery
2) By Patient Care Setting: Hospitals, Diagnostic Centers, Ambulatory Surgery Centers/Clinics, Home Care Settings, Other Patient Care Settings
3) By Application: Cancer, Infectious Diseases, Respiratory Diseases, Diabetes, Cardiovascular Diseases, Autoimmune Diseases, Central Nervous System Disorders, Other Applications
For further insights on the drug delivery devices market, request a sample here

North America was the largest region in the drug delivery devices market in 2022. For detailed insights on the largest region's market size and growth rate, request a sample here.

Key competitors in the drug delivery devices market are, F. Hoffmann-La Roche Ltd, 3M Company, Pfizer Inc., Baxter International, BD., Novartis AG, Gerresheimer AG, Johnson & Johnson Services, Inc., Bayer AG, GlaxoSmithKline plc, B. Braun Melsungen AG, Cipla Inc., Boehringer Ingelheim, Antares Pharma, Sulzer Ltd, Sanofi, Novosanis, MEDMIX SYSTEMS AG, Merck & Co., Inc., Insulet Corporation, OraSure Technologies, Inc., Enable Injections, West Pharmaceutical Services, Inc., SMC Ltd., ViVO Smart Medical Devices Ltd., Smith Medical, CareFusion Corporation, Abbott Laboratories, Nipro Corporation, Allergan, Catalent. For further insights on the drug delivery devices market, request a sample here.

Major trends influencing the drug delivery devices market include collaborating with other companies within the industry in order to strengthen their product portfolio as well as expand their footprint across different geographies. For further insights on the drug delivery devices market, request a sample here.

For detailed insights on the major opportunities and strategies in the drug delivery devices market, request a sample here.

For detailed insights on drug delivery devices market's relation to the overall economy and other similar markets, request a sample here.

For detailed insights on the mergers and acquisitions in the drug delivery devices industry, request a sample here.

For detailed insights on the key dynamics influencing the drug delivery devices market growth and SWOT analysis of the drug delivery devices industry, request a sample here.